Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131924) titled 'A Phase II Clinical Study to Evaluate the Efficacy and Safety of Hypofractionated Radiotherapy Combined with Granulocyte-Macrophage Colony-Stimulating Factor, Pomalidomide and Glofitamab in Patients with Newly Diagnosed Primary Central Nervous System Diffuse Large B-Cell Lymphoma' on Sept. 7.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Xiamen University
Condition:
Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-09-07
Target Sample Size: experimental g...